Envisagenics, Cancer Research Horizons, and Queen Mary University of London Announce Strategic Collaboration Agreement
/PRNewswire/ -- Envisagenics, an Artificial Intelligence ("AI")-driven biotechnology company that delivers therapies for RNA splicing diseases, today announced...